Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001125282-06-002196
Filing Date
2006-04-12
Accepted
2006-04-12 16:09:23
Documents
14
Period of Report
2006-05-23
Effectiveness Date
2006-04-12

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A b412685_def14a.htm DEF 14A 268753
2 GRAPHIC arrow.jpg GRAPHIC 1082
3 GRAPHIC chart.jpg GRAPHIC 34284
4 GRAPHIC clement_sig.jpg GRAPHIC 4542
5 GRAPHIC dot-big.jpg GRAPHIC 10734
6 GRAPHIC dot-empty.jpg GRAPHIC 985
7 GRAPHIC emptybox.gif GRAPHIC 861
8 GRAPHIC number.jpg GRAPHIC 11418
9 GRAPHIC punch.jpg GRAPHIC 10613
10 GRAPHIC savient_logo.jpg GRAPHIC 8793
11 GRAPHIC square.jpg GRAPHIC 10642
12 GRAPHIC square1.jpg GRAPHIC 10890
13 GRAPHIC tickedbox.gif GRAPHIC 897
14 GRAPHIC yachmetz_sig.jpg GRAPHIC 5896
  Complete submission text file 0001125282-06-002196.txt   425913
Mailing Address ONE TOWER CENTER EAST BRUNSWICK NJ 08816
Business Address ONE TOWER CENTER EAST BRUNSWICK NJ 08816 7324189300
SAVIENT PHARMACEUTICALS INC (Filer) CIK: 0000722104 (see all company filings)

EIN.: 133033811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-15313 | Film No.: 06756106
SIC: 2833 Medicinal Chemicals & Botanical Products